Wyeth has named Bernard Poussot its new CEO.
Simon Lowth, an outsider, has been picked as AstraZeneca's CFO.
Jack Anthony is resigning from VaxGen Board and accepting the CEO spot at Osprey Pharmaceutical Company.
Corey Goodman, Ph.D., will step down as President and CEO of Renovis to pursue another opportunity.
Francois-Xavier Frapaise, M.D., has joined Asphelia Pharmaceuticals as its President and CEO.
Moberg Derma has appointed Tommy Nilsson as the new CEO.
Anthony D. Squeglia has been named CFO of Pro-Pharmaceuticals, and Steven Schubert Vice President, Finance on a consulting basis.
Dr. Glenn E. Nedwin, President, Chief Scientific Officer and Executive Vice President of Dyadic International, has resigned.
Synvista Therapeutics has appointed Carl M. Mendel, M.D. as Vice president, Clinical Development and Chief Medical Officer.
Gregory L. Sheldon as been named CIO of Mylan Laboratories.
Ikaria has chosen Ralf Rosskamp, M.D., as Executive Vice President of R&D.
Anacor Pharmaceuticals has named Paul Cleveland to the company's Board of Directors.
Mitchell D. Kaye has been elected to Genaera's Corporation Board of Directors. The Board also elected Henry R. Wolfe, Ph.D., as Executive Vice President and Chief Scientific Officer, and Michael J. Gast, M.D., Ph.D., as Executive Vice President and Chief Medical Officer.
Othera Pharmaceuticals has named Dr. Frederick R. Rickles Chief Scientific Officer.
Dr. M. Flint Beal has been appointed to Avicena Group's Board of Directors.
Sigma-Aldrich has named Patrick Sullivan as its new VP of R&D for Research Biotech.
Dr. Gary E. Costley has been elected to Covance's Board.
Wyeth has elected Robert M. Amen to the Board of Directors.
Steven Brugger has assumed the newly-created position of Chief Operating Officer at Momenta. Ganesh Venkataraman, Ph.D. has become the company's first Chief Scientific Officer.
Celsion Corporation has chosen Nicholas Borys, M.D. as Vice President and Chief Medical Officer.
Jeremy Levin has joined Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing.
Cougar Biotechnology has appointed Samuel Saks to its Board of Directors.
Adrian Haigh has been named Vice President Global Marketing at EUSA Pharma.
Idera Pharmaceuticals has appointed Hans Mueller, Ph.D. to its Board.
Pfizer has election Suzanne Nora Johnson and James M. Kilts to the company's Board of Directors.